
### [NCIT:C3692](http://purl.obolibrary.org/obo/NCIT_C3692)
**Label:** Undifferentiated Carcinoma

**Subclasses:** [NCIT:C35718](http://purl.obolibrary.org/obo/NCIT_C35718) (Thymic Undifferentiated Carcinoma), [NCIT:C96792](http://purl.obolibrary.org/obo/NCIT_C96792) (Undifferentiated Liver Carcinoma), [NCIT:C5946](http://purl.obolibrary.org/obo/NCIT_C5946) (Parotid Gland Undifferentiated Carcinoma), [NCIT:C6159](http://purl.obolibrary.org/obo/NCIT_C6159) (Undifferentiated Ureter Carcinoma), [NCIT:C4452](http://purl.obolibrary.org/obo/NCIT_C4452) (Lung Giant Cell Carcinoma), [NCIT:C27419](http://purl.obolibrary.org/obo/NCIT_C27419) (Ampulla of Vater Undifferentiated Carcinoma), [NCIT:C54294](http://purl.obolibrary.org/obo/NCIT_C54294) (Sinonasal Undifferentiated Carcinoma), [NCIT:C9167](http://purl.obolibrary.org/obo/NCIT_C9167) (Undifferentiated Gallbladder Carcinoma), [NCIT:C63622](http://purl.obolibrary.org/obo/NCIT_C63622) (Undifferentiated Carcinoma with Osteoclast-Like Giant Cells), [NCIT:C7100](http://purl.obolibrary.org/obo/NCIT_C7100) (Colon Undifferentiated Carcinoma), [NCIT:C5780](http://purl.obolibrary.org/obo/NCIT_C5780) (Extrahepatic Bile Duct Undifferentiated Carcinoma), [NCIT:C6281](http://purl.obolibrary.org/obo/NCIT_C6281) (Undifferentiated Fallopian Tube Carcinoma), [NCIT:C95965](http://purl.obolibrary.org/obo/NCIT_C95965) (Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells), [NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma), [NCIT:C5947](http://purl.obolibrary.org/obo/NCIT_C5947) (Submandibular Gland Undifferentiated Carcinoma), [NCIT:C7906](http://purl.obolibrary.org/obo/NCIT_C7906) (Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant), [NCIT:C35735](http://purl.obolibrary.org/obo/NCIT_C35735) (Salivary Gland Large Cell Carcinoma), [NCIT:C54339](http://purl.obolibrary.org/obo/NCIT_C54339) (Laryngeal Undifferentiated Carcinoma), [NCIT:C5954](http://purl.obolibrary.org/obo/NCIT_C5954) (Minor Salivary Gland Undifferentiated Carcinoma), [NCIT:C3878](http://purl.obolibrary.org/obo/NCIT_C3878) (Thyroid Gland Undifferentiated (Anaplastic) Carcinoma), [NCIT:C3779](http://purl.obolibrary.org/obo/NCIT_C3779) (Giant Cell Carcinoma), [NCIT:C27422](http://purl.obolibrary.org/obo/NCIT_C27422) (Esophageal Undifferentiated Carcinoma), [NCIT:C43591](http://purl.obolibrary.org/obo/NCIT_C43591) (Colorectal Undifferentiated Carcinoma), [NCIT:C7974](http://purl.obolibrary.org/obo/NCIT_C7974) (Rectal Undifferentiated Carcinoma), [NCIT:C54342](http://purl.obolibrary.org/obo/NCIT_C54342) (Laryngeal Giant Cell Carcinoma), [NCIT:C6345](http://purl.obolibrary.org/obo/NCIT_C6345) (Cervical Undifferentiated Carcinoma), [NCIT:C6168](http://purl.obolibrary.org/obo/NCIT_C6168) (Undifferentiated Urethral Carcinoma), [NCIT:C5597](http://purl.obolibrary.org/obo/NCIT_C5597) (Prostate Undifferentiated Carcinoma), [NCIT:C5476](http://purl.obolibrary.org/obo/NCIT_C5476) (Undifferentiated Gastric Carcinoma), [NCIT:C8024](http://purl.obolibrary.org/obo/NCIT_C8024) (Salivary Gland Undifferentiated Carcinoma), [NCIT:C43556](http://purl.obolibrary.org/obo/NCIT_C43556) (Appendix Undifferentiated Carcinoma), [NCIT:C43538](http://purl.obolibrary.org/obo/NCIT_C43538) (Small Intestinal Undifferentiated Carcinoma), [NCIT:C45716](http://purl.obolibrary.org/obo/NCIT_C45716) (NUT Midline Carcinoma), [NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma), [NCIT:C5838](http://purl.obolibrary.org/obo/NCIT_C5838) (Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type), [NCIT:C96529](http://purl.obolibrary.org/obo/NCIT_C96529) (Anal Canal Undifferentiated Carcinoma), [NCIT:C4509](http://purl.obolibrary.org/obo/NCIT_C4509) (Undifferentiated Ovarian Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C37085](http://purl.obolibrary.org/obo/NCIT_C37085) (Undifferentiated Carcinoma Cell) 54.55%
- Thing 52.66%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 39.90%


